Trials / Completed
CompletedNCT00966576
Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy
The Efficacy and Safety of Adding the Brinzolamide/Timolol Maleate Fixed Combination (Azarga®) to Prostaglandin Monotherapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of adding AZARGA in glaucoma patients with uncontrolled intraocular pressure (IOP), currently on prostaglandin monotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brinzolamide/Timolol Maleate Fixed Combination (AZARGA) | 1 drop of study medication into the study eye(s) beginning the evening of Visit 1 and continuing twice daily (morning and evening) for 12 weeks |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2009-08-27
- Last updated
- 2016-11-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00966576. Inclusion in this directory is not an endorsement.